SCHEMBL6350787

SCHEMBL6350787

N#Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCc4cc(Cl)ccc43)c2)c(C(=O)O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.63
PPARD Q03181 8/20 0.63
PPARA Q07869 7/20 0.63
ALB P02768 1/20 0.57
TNF P01375 1/20 0.57
NOD2 Q9HC29 1/20 0.57
NOD1 Q9Y239 1/20 0.57
MAPT P10636 3/20 0.56
NR3C1 P04150 1/20 0.55
AR P10275 1/20 0.55
TP53 P04637 1/20 0.53
LMNA P02545 1/20 0.52
STAT3 P40763 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CASP3 P42574 1/20 0.52
SENP8 Q96LD8 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350657 0.94 PPARG (0.59) PPARGPPARDPPARAALBTNF
SCHEMBL6346501 0.92 PPARG (0.53) PPARGPPARDPPARAALBTNF
SCHEMBL6357250 0.91 MAPT (0.56) PPARGPPARDPPARATNFNOD2
SCHEMBL6348623 0.91 ALB (0.62) PPARGPPARDPPARAALBMAPT
SCHEMBL6358617 0.91 NR3C1 (0.67) PPARGPPARDPPARATNFNOD2
SCHEMBL6346544 0.89 PPARG (0.66) PPARGPPARDPPARAALBTNF
SCHEMBL6351239 0.88 PPARG (0.65) PPARGPPARDPPARAALBTNF
SCHEMBL6351428 0.88 PPARG (0.65) PPARGPPARDPPARAALBTNF
SCHEMBL6358782 0.87 PPARG (0.64) PPARGPPARDPPARAALBTNF
SCHEMBL6356719 0.87 PPARG (0.64) PPARGPPARDPPARAALBTNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 PPARG 3572/4885PPARD 2519/4885PPARA 2335/4885
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PPARG 262/4885PPARD 144/4885PPARA 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.